Subsequent Financing. The Note is intended to provide necessary bridge financing to the Company prior to an anticipated financing in the near future of an amount up to $1,752,000 which is expected to be structured as convertible preferred stock (the "Preferred Financing"). Upon the closing of the Preferred Financing, the Note shall automatically convert into the Preferred Financing."
Appears in 1 contract
Samples: Securities Purchase Agreement (Boston Therapeutics, Inc.)
Subsequent Financing. The Note is intended to provide necessary bridge financing to the Company prior to an anticipated financing in the near future of an amount up to $1,752,000 1,050,000 which is expected to be structured as convertible preferred stock (the "Preferred Financing"). Upon the closing of the Preferred Financing, the Note shall automatically convert into the Preferred Financing."
Appears in 1 contract
Samples: Securities Purchase Agreement (Boston Therapeutics, Inc.)
Subsequent Financing. The Note is intended to provide necessary bridge financing to the Company prior to an anticipated financing in the near future of an amount up to $1,752,000 1,450,000 which is expected to be structured as convertible preferred stock (the "Preferred Financing"). Upon the closing of the Preferred Financing, the Note shall automatically convert into the Preferred Financing."
Appears in 1 contract
Samples: Securities Purchase Agreement (Boston Therapeutics, Inc.)
Subsequent Financing. The This Note is intended to provide necessary bridge financing to the Company prior to an anticipated financing in the near future of an amount up to $1,752,000 750,000 which is expected to be structured as convertible preferred stock (the "Preferred Financing"). Upon the closing of the Preferred Financing, the this Note shall automatically convert into the Preferred Financing."
Appears in 1 contract
Samples: Convertible Promissory Note (Boston Therapeutics, Inc.)
Subsequent Financing. The Note is intended to provide necessary bridge financing to the Company prior to an anticipated financing in the near future of an amount up to $1,752,000 1,702,000 which is expected to be structured as convertible preferred stock (the "Preferred Financing"). Upon the closing of the Preferred Financing, the Note shall automatically convert into the Preferred Financing."
Appears in 1 contract
Samples: Securities Purchase Agreement (Boston Therapeutics, Inc.)
Subsequent Financing. The Note is intended to provide necessary bridge financing to the Company prior to an anticipated financing in the near future of an amount up to $1,752,000 1,200,000 which is expected to be structured as convertible preferred stock (the "Preferred Financing"). Upon the closing of the Preferred Financing, the Note shall automatically convert into the Preferred Financing."
Appears in 1 contract
Samples: Securities Purchase Agreement (Boston Therapeutics, Inc.)
Subsequent Financing. The Note is intended to provide necessary bridge financing to the Company prior to an anticipated financing in the near future of an amount up to $1,752,000 750,000 which is expected to be structured as convertible preferred stock (the "Preferred Financing"). Upon the closing of the Preferred Financing, the Note shall automatically convert into the Preferred Financing."
Appears in 1 contract
Samples: Securities Purchase Agreement (Boston Therapeutics, Inc.)
Subsequent Financing. The Note is intended to provide necessary bridge financing to the Company prior to an anticipated financing in the near future of an amount up to $1,752,000 1,602,000 which is expected to be structured as convertible preferred stock (the "Preferred Financing"). Upon the closing of the Preferred Financing, the Note shall automatically convert into the Preferred Financing."
Appears in 1 contract
Samples: Securities Purchase Agreement (Boston Therapeutics, Inc.)